The short version of reference standard fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-11-21. Anything still debated is marked as such rather than presented as settled.
The molecule is a synthetic 39-amino-acid peptide whose backbone derives from the sequence of human glucose-dependent insulinotropic polypeptide, with several substitutions that raise metabolic stability and shift receptor preference. A C20 fatty diacid is attached through a short linker to a lysine side chain, a modification that increases binding to serum albumin. The reported monoisotopic mass is approximately 4813 Da. Near neutral pH the peptide carries a net negative charge, and the lipid tail makes the molecule markedly more hydrophobic than the unmodified parent sequence.
Dual agonism at the GIP and GLP-1 receptors underlies the observed pharmacology. Activation of GLP-1 receptors raises glucose-dependent insulin release, lowers glucagon secretion, slows gastric emptying and reduces appetite. GIP receptor activation contributes additional effects on adipose tissue and on energy balance, and the combined action on appetite appears larger than either pathway alone in animal models. Signalling bias and the relative contribution of each receptor arm to weight-related effects remain areas of active investigation.
Solid tirzepatide is handled as a lyophilised, hygroscopic peptide powder that should be kept desiccated, protected from light, and stored frozen, typically at or below minus twenty degrees Celsius for long-term retention. Material left at ambient temperature for extended periods can take up moisture, which promotes aggregation and deamidation. Commercial liquid presentations are kept refrigerated between two and eight degrees Celsius and are not frozen. Reconstituted laboratory solutions are generally held cold and used within a short window because hydrolysis and oxidation continue slowly in solution.
Identity and purity are usually established with reversed-phase high-performance liquid chromatography for the main peak and with mass spectrometry for the observed molecular mass. Peptide mapping after enzymatic digestion confirms the primary sequence, while amino acid analysis provides a quantitative composition check. Size-exclusion chromatography and ion-exchange chromatography are used to look for aggregates and charge variants. Water content, residual solvents, and counter-ion content are measured separately, since a lyophilised powder is often reported on an as-is basis unless a correction is applied.
Research-grade material circulates through suppliers that differ widely in documentation and testing practice, so a certificate of analysis is a starting point rather than proof of quality. Independent verification typically repeats chromatographic purity and mass confirmation on the received lot, and compares results against a retained reference standard. Regulatory status varies by jurisdiction, and a substance cleared as a medicine is not interchangeable with a research chemical of the same name. Open questions include how closely non-pharmaceutical lots match approved material in impurity profile and in aggregate content.
| Property | Value | Notes |
|---|---|---|
| Molar mass | approximately 4813 Da | calculated from the 39-residue sequence |
| Appearance | white to off-white powder | typical of lyophilised peptide material |
| Solubility class | freely soluble in water | measured value depends on salt form and pH |
| Plasma protein binding | >99 percent | linked to the fatty diacid side chain |
| Class | dual GIP and GLP-1 receptor agonist | receptor activity varies with the assay used |
Tirzepatide is a synthetic peptide that acts as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. The molecule contains 39 amino acids and features a C20 fatty diacid moiety attached via a linker, which promotes albumin binding and extends its circulating half-life. Its sequence incorporates non-natural amino acids and modifications that reduce susceptibility to degradation by dipeptidyl peptidase-4. This dual receptor activity distinguishes it from selective GLP-1 receptor agonists.
The GIP receptor is expressed in pancreatic islets, adipose tissue, and the central nervous system, while GLP-1 receptors are found in pancreatic islets, the gastrointestinal tract, and the brain. Activation of both receptors can enhance glucose-dependent insulin secretion and reduce glucagon release. The relative contribution of each receptor to the overall pharmacological effect remains an area of ongoing investigation. Preclinical studies suggest that GIP receptor agonism may modulate appetite and energy balance, but the precise mechanisms in humans are not fully established.
Recommended storage for reference material is a freezer at approximately -20 degrees Celsius, protected from light and moisture. Commercial injectable presentations are stored refrigerated between 2 and 8 degrees Celsius and must not be frozen. Product labelling generally permits a limited period at controlled room temperature once dispensed, with the exact window depending on the presentation. Repeated temperature cycling is avoided because it can promote aggregation or deamidation of the peptide chain.
Identity and purity are assessed by reversed-phase high-performance liquid chromatography, with mass confirmation by electrospray ionisation mass spectrometry. Peptide mapping after enzymatic digestion verifies the primary sequence. Size-exclusion chromatography quantifies aggregates, while circular dichroism provides a secondary-structure fingerprint. Bioanalytical quantification in plasma uses immunoassay or LC-MS/MS. Reported purity for research-grade lots is commonly 95 percent or higher, and residual water content is checked by Karl Fischer titration.
Tirzepatide is a synthetic peptide composed of 39 amino acids. It acts as a dual agonist at two incretin receptors, the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. The molecule was designed by modifying the native sequence of glucose-dependent insulinotropic polypeptide to improve metabolic stability and extend its circulation time. Its structure includes several non-natural amino acid residues and a fatty acid side chain. These features distinguish it from earlier single-receptor incretin analogs studied in the same period.
The compound first appeared in the scientific literature as an investigational agent for type 2 diabetes. Clinical development proceeded through phase 1, phase 2, and phase 3 programs that measured glycemic control as a primary endpoint while recording body weight as a secondary outcome. Regulatory approval in the United States followed in 2022 for glycemic control, and a separate indication for chronic weight management was added later. Subsequent trials have examined cardiovascular outcomes in adults with elevated cardiovascular risk. Debates continue over how much of the observed effect derives from each receptor arm.
Structural work on the molecule centers on a C20 fatty diacid moiety attached through a linker to the peptide backbone. This side chain promotes reversible binding to serum albumin, which slows renal clearance and supports a prolonged action profile. The peptide backbone incorporates aminoisobutyric acid substitutions that limit recognition by digestive enzymes. Together these modifications produce a molecule that is stable enough for subcutaneous delivery but still dependent on careful manufacturing control. Analytical characterization of the active pharmaceutical ingredient typically follows the conventions used for other synthetic peptides.
Stability depends strongly on physical form. The dry powder is generally regarded as stable for extended periods when held at or below minus twenty degrees Celsius in a sealed, desiccated container. In solution, degradation pathways include deamidation of asparagine and glutamine residues, oxidation of methionine, and aggregation. Reaction rates for these pathways rise with temperature. Repeated freezing and thawing of solutions promotes aggregation, and light exposure can accelerate some oxidative changes. Buffer composition and pH influence which pathway dominates at a given temperature.
Regulatory and quality discussions place the peptide within established guidance for synthetic peptides and biologics. Forced degradation studies, in which samples are exposed to heat, acid, base, peroxide, and light, identify likely degradation products and validate the selectivity of analytical methods. Reference standards allow comparison across laboratories and production batches. Purity specifications reported in the literature usually combine chromatographic purity with mass confirmation. Which impurity thresholds are meaningful for long-term behavior is still debated, and no single universal specification has been adopted across all jurisdictions.
Routine characterization of the peptide relies on reversed-phase high-performance liquid chromatography for purity assessment, usually with ultraviolet detection near 214 nanometers. Intact mass measurement by liquid chromatography coupled to mass spectrometry confirms molecular identity against a theoretical value. Sequence-level confirmation uses enzymatic digestion followed by tandem mass spectrometry, an approach known as peptide mapping. Amino acid analysis gives an independent check on composition. Circular dichroism spectra are used to estimate helical content in aqueous buffer.
== Function == Renin activates the renin–angiotensin system by using its endopeptidase activity to cleave the peptide bonds between leucine and valine residues in angiotensinogen, produced by the liver, to yield angiotensin I, which is further converted into angiotensin II by ACE, the angiotensin–converting enzyme primarily within the capillaries of the lungs. Angiotensin II then constricts blood vessels, increases the secretion of ADH and aldosterone, and stimulates the hypothalamus to activate the thirst reflex, each leading to an increase in blood pressure. Renin's primary function is therefore to eventually cause an increase in blood pressure, leading to restoration of perfusion pressure in the kidneys. Renin is secreted from juxtaglomerular kidney cells, which sense changes in renal perfusion pressure, via stretch receptors in the vascular walls. The juxtaglomerular cells are also stimulated to release renin by signaling from the macula densa. The macula densa senses changes in sodium delivery to the distal tubule, and responds to a drop in tubular sodium load by stimulating renin release in the juxtaglomerular cells. Together, the macula densa and juxtaglomerular cells comprise the juxtaglomerular complex. Renin secretion is also stimulated by sympathetic nervous stimulation, mainly through β1 adrenoreceptor activation.
A rare, but serious, side effect is propofol infusion syndrome. This potentially lethal metabolic derangement has been reported in critically ill patients after a prolonged infusion of high-dose propofol, sometimes in combination with catecholamines and/or corticosteroids.
=== Reduction of metal salts and oxides === Many metal carbonyls are prepared by reductive carbonylation. This method entails the reduction of metal halides in the presence of carbon monoxide, often at high pressures. A variety of reducing agents are employed, including copper, aluminum, hydrogen, as well as metal alkyls such as triethylaluminium. Illustrative is the formation of chromium hexacarbonyl from anhydrous chromium(III) chloride in benzene with aluminum as a reducing agent, and aluminum chloride as the catalyst:
Sources: en.wikipedia.org
== External links == Thabo Mbeki's "I am an African" speech Mbeki's 1998 speech outlining the African Renaissance AfricAvenir's collection of African Renaissance materials The "African Renaissance" at The Crossroads of Postcoloniality and Postmodernity
protein complex An assembly or aggregate of multiple proteins held together by intermolecular forces, especially one with a particular biological function. Complexes may include many of the same protein or all different proteins. Numerous cellular activities, including DNA replication, transcription, and translation, rely on protein complexes.
=== Astrophysics === MHD applies to astrophysics, including stars, the interplanetary medium (space between the planets), the interstellar medium (space between the stars), and jets. Most astrophysical systems are not in local thermal equilibrium and therefore require an additional kinematic treatment to describe all the phenomena within the system (see Astrophysical plasma). Sunspots are caused by the Sun's magnetic fields, as Joseph Larmor theorized in 1919. The solar wind, predicted by Eugene Parker, is also described by MHD. The differential solar rotation may be the long-term effect of magnetic drag at the Sun's poles, an MHD phenomenon resulting from the Parker spiral shape of the Sun's extended magnetic field. Previously, theories describing the formation of the Sun and planets could not explain how the Sun contains 99.87% of the mass, yet only 0.54% of the angular momentum, in the Solar System. In a closed system, such as the cloud of gas and dust from which the Sun formed, mass and angular momentum are both conserved. That conservation would imply that, as the mass concentrated at the center of the cloud to form the Sun, it would spin faster, much like a skater pulling in their arms. The high rotational speed predicted by early theories would have flung the proto-Sun apart before it could form. However, magnetohydrodynamic effects transfer the Sun's angular momentum to the outer solar system, slowing its rotation. Breakdown of ideal MHD, in the form of magnetic reconnection, is thought to be the likely cause of solar flares.
Sources: en.wikipedia.org
== Structure of penicillin binding protein 3 == Penicillin binding protein 3 is important for bacteria wall synthesis and is a main target in β-lactam antibiotics. It is a two-domain protein containing a C-terminal transpeptidase linked to an extended N-terminal domain. This protein is similar to other class B PBP’s since it contains an α-helical subdomain or “head” domain towards the N-terminus. The N-terminal domain’s function is still not known but it is thought it serves to position the transpeptidase domain away from the inner membrane as part of a multienzyme complex involved in cell wall biosynthesis.
In biochemistry, biomolecular condensates are a class of membrane-less organelles and organelle subdomains, which carry out specialized functions within the cell. Unlike many organelles, biomolecular condensate composition is not controlled by a bounding membrane. Instead, condensates can form and maintain organization through a range of different processes. The most well-known process is phase separation of proteins, RNA, and other biopolymers into either colloidal emulsions, gels, liquid crystals, solid crystals, or protein aggregates within cells.
Warden III, who largely planned the USAF attacks; within ten minutes of the attacks by 21 F117 aircraft on 38 targets, Iraq had lost its communications and radar; Lt-Col David Deptula; in the first wave were 4 Saudi Arabian Tornado aircraft, 4 Grumman A-6 Intruder and SEAD McDonnell Douglas F-4G Wild Weasel V aircraft, 5 Northrop Grumman EA-6B Prowler aircraft to provide electronic jamming of the Iraq airspace, and 21 McDonnell Douglas F/A-18 Hornet aircraft, each which dropped the AGM-88 HARM anti-radiation missile, to destroy the Iraq surface to air missile capability; Tomahawk missiles were fired from battleships in the Gulf and submarines in the Red Sea; the General Dynamics F-111 had around four thousand gallons of fuel; before advanced guidance systems for munitions, munitions would land according to the circular error probability, which was around a half-mile for a B-17 in World War II; the first laser-guided munitions were the Pave Tack system, which debuted on the F-111 in 1982, first deployed by F-111 aircraft from RAF Lakenheath; Duncan Lennox, editor of Jane's Strategic Weapon Systems; Theodore Postol; on one evening, twenty-eight MIM-104 Patriot missiles were launched against five ballistic missiles, which had broken up on re-entry to the earth's atmosphere - hitting any of these fractured ballistic missiles was almost impossible, due to the unforeseen changing aerodynamics; Lt-Col George Cusimano, deputy director of the USAF joint; the joint also deployed synthetic-aperture radar, to give a fuller view of ground forces, from the AN/APG-76 Doppler radar; the ground picture could be relayed to ground forces, such as in the Battle of Khafji on 29 January 1991; Royal Scots 1st Battalion, with GKN Warrior tracked armoured vehicles and Major John Potter; the experimental Ferranti TIALD laser-guided munitions were deployed by RAF Panavia Tornado aircraft to destroy Iraq hardened aircraft shelters in February 1991; 39th Regiment Royal Artillery deployed the M270 Multiple Launch Rocket System (MLRS); the land battle began on 24 February 1991, watched by the DOAE in Surrey; the land war did not last long, and on 26 February 1991 retreating Iraqi vehicles and tanks were systematically destroyed by AGM-114 Hellfire missiles, launched from undetected Boeing AH-64 Apache helicopters, resulting in total destruction; the USS Wisconsin battleship fired at Failaka Island, with surveillance provided by its AAI RQ-2 Pioneer drone. Narrated by Edward Hardwicke, directed by Chris Haws, produced by Richard Melman, made by InCA Productions 18 August The Healing Mind, about the field of psychoneuroimmunology; psychiatrist Janice Kielcolt-Glaser of Ohio State University College of Medicine; psychologist Barrie R. Cassileth; chemical pathologist Malcolm Carruthers takes a blood sample from a candidate, who has been driven around Brands Hatch at 115 mph; Theodore Melnechuk of the University of California; the body's immune system - the phagocytes destroy foreign bacteria, the natural killer cells destroy the body's own cells that are too damaged, and the lymphocyte T cells and B cells remember pathogens, with a corresponding antibody; experimental psychologist Robert Ader of the University of Rochester Medical Center conducted research on rats in 1975, with cyclophosphamide, which weakens the immune system, and immunologist Nicholas Cohen; prolonged secretion of endogenous opioid peptides may lower the immune function; neuroscientist David L. Felten of the University of Rochester; psychoimmunologist Nick Hall of the University of South Florida College of Medicine and an experiment with drama students, where lowering of T cells was found; Kathleen Dillon of Western New England College, where an experiment measured Ig A of candidates who watched types of television content, and found that Ig A temporarily increased with amusing content; psychiatrist Fawzy Fawzy of the University of California; psychiatrist Margaret Kemeny of UCLA. Narrated by Geoff Watts (of Radio 4's former Science Now series, produced by Geoff Deehan in the 1970s), directed by Yavar Abbas, produced by Geoff Deehan, made by Sandlin Productions 25 August Spacesuit, the spacesuits that astronauts wore during the Apollo missions to the Moon, and whether such spacesuits would be advanced enough to be worn for future missions to Mars; by 2020, NASA expected to have landed on Mars; at sea-level, air pressure is 14 PSI; ILC Dover in Newark, Delaware has made all NASA spacesuits since the late 1960s; medical research at the Ames Research Center; Joe Kosmo, head of NASA spacesuit design; the invention of the defecation-mitten by Matthew Radnofsky; Bruce Webbon of the Ames Research Centre; the Johnson Space Center also worked on suit design. Directed by Patrick Uden, made by Uden Associates 1 September The Falls, about the Niagara Falls. Produced by Clare Odgers, made by the National Film Board of Canada and Primitive Features 8 September Re-inventing Japan, looking at Japan's success in applied science, contrasted with less success in pure science and whether Japan could enhance its pure science industry enough, which has connections with a country's own cultural values and outlook, and how Britain has excelled in pure science, but how much that university funding cuts could erode Britain's prowess in pure science; Japan few Nobel prizes, but excelled at applied science and exploiting others' research by reverse engineering; Canon had £6bn of sales, of which 40% were photocopiers, such as the L5; Hajime Mitarai, research director of Canon, and how Canon had eight product divisions, with their own engineering staff in each division, with process physicists and inorganic chemists; with Western science innovations, it often came from a set of individuals, whereas Japan's innovation culture revolved around much intense group cooperation, not individuals; Japan had only won five Nobel prizes since the 1950s - the US had won 135; a youthful Matt Ridley of The Economist; Fujitsu was the world's second-largest manufacturer of computers, and had bought ICL (which had been Ferranti) in 1990, and sold £10bn a year; Naoki Yokoyama and Takahiko Misugi of Fujitsu; Japan could not rely on other countries research anymore, and had to conduct more in-house research; Japan's culture was not greatly known for originality or taking risks, or being surprised; pathologist Sir Anthony Epstein and how Japan greatly revered tradition, and conformity, possibly viewing anyone who didn't likewise confirm as troublesome; electrical engineer Hiroya Fujisaki, of Tokyo University and known for the Fujisaki model, and that he thought that Japan's culture had historically eroded originality; the national research organisation Riken was formed in 1917, and made great progress, with a large cyclotron, and visited by Einstein in December 1922, but the US was suspicious after the war, and destroyed Riken's cyclotron; Minoru Oda, head of Riken from 1988 to 1993; the US distrusted Japan, and preferred Japan to work on mainly applied science; physicist Akira Tonomura at the Hitachi Advanced Laboratory, which had the world's largest electron microscope; Shojiro Asai of Hitachi; the Canon Advanced Research Laboratory; the Tsukuba Science City and the University of Tsukuba, built by the Japanese government for £6bn, and home of the Japanese ERATO science innovation agency; Genya Chiba, director of ERATO; Michio Nagai, former minister of education in the mid-1970s. Directed by Bob Bee, produced by Michael Wills (later Labour MP from 1997 to 2010 for North Swindon), and made by Juniper Productions 13 September Theme Park Heaven, Walt Disney; Sylvère Lotringer of Columbia University; Arrow Dynamics of California, with Dal Freeman Ron Toomer; David Lewis; Cedar Point, built by Custom Coasters International of Cincinnati; Eric Westin of Walt Disney Imagineering, and the Big Thunder Mountain Railroad ride; Marc Davis, who drew Tinkerbell in Peter Pan, and who worked on the Pirates of the Caribbean ride, which opened in 1967; Larry Lester and David Codiga of Universal Studios, and their earthquake Studio Tour and Backdraft rides; Dreamland in 1912; psychologist Timothy Leary; Douglas Trumbull and the Back to the Future: The Ride and Luxor Las Vegas; Stan Kinsey of SimEx-Iwerks; Michael Ryder and Thom Dickeson of Evans & Sutherland, and texture mapping onto polygons, a main feature of transportation simulations; Bob Stone of the Advanced Robotics Research Centre at the University of Salford. Narrated by Richard O'Brien, produced by Jerome Kuehl, directed by Graham Moore, made with WGBH and Open Media 22 September The Professor's New Clothes, a re-broadcast of an Australian documentary about Professor Vishwa Jit Gupta of Panjab University and his fraudulent work about paleontology of the Himalayas. Directed by Stephen Ramsey, produced by Janet Bell, and made by Film Australia 29 September The Gambler's Guide to Winning, the ways of deploying mathematical techniques to win in gambling, with probability theory methods developed by Prof Edward O. Thorp of University of California, Irvine; the disastrous 1967 Grand National, where nearly all the horses fell at the 23rd fence; Frank Honywill George of Brunel University; Ralph Abraham of University of California, Santa Cruz; Peter A. Griffin of California State University, Sacramento; the gambler's fallacy; J. Doyne Farmer of the Santa Fe Institute. Narrated by Andrew Burt, directed by Julian Nott (son of the Conservative former defence secretary Sir John Nott, who later composed the music for Wallace and Gromit films such as The Wrong Trousers), produced by Jenny Barraclough, made by Peninsula Films 6 October Superpowers?, with Ray Hyman, about the international group of sceptics Committee for Skeptical Inquiry, who dispute topics such as UFOs, made by Open Media 13 October The Lean Burn Machine, about the development of catalytic converters for automotive engines, and how they cause more fuel to be burned than before, and the British engineer Geoffrey West who has produced an alternative, but faced restrictions from EC (EU) legislation; Europe introduced pollution legislation in July 1992; California had the worst vehicle pollution in the US, notably LA; the Clean Air Act; Rob Searles of Johnson Matthey; German environment minister Bernd Schmidbauer - Germany had over two-thirds of European car exports to the US; French physicist Hubert Curien, Minister of Higher Education, Research and Innovation from 1988 to 1993; chemistry graduate Margaret Thatcher being interviewed on 2 March 1989 on the BBC, and lean-burn engines; Bernard Bertrand, head of engine development of Peugeot; Shillington of BL; the new EC legislation in 1992 would outlaw lean-burn powered cars; Dutch automotive writer Gerard Sauer. Narrated by Nick Ross, directed by Nick Abson and Simon Broom, produced by Michael Blakstad (Editor from 1974 of Tomorrow's World), made by Workhouse 20 October The Elements, the poet Roger McGough narrates poetry for each element and how the Periodic Table came to be formed; 5% of the Earth's crust is iron; xenon is found in strobe lights; argon is in domestic incandescent light bulbs; the light bulb filament is tungsten, but reserves of tungsten are low. Directed by Ian Duncan, produced by David Dugan, made by Windfall Films (part of Argonon). Shown on 25 November 1992 on The Nature of Things in Canada 27 October The Strange Case of Crop Circles, an update to the documentary made in 1990, looking at why the 250 crop circles that appeared in the summer, that around 50% of the circles appeared in Wiltshire; the phenomenon took off after a circle near Westbury was pictured in a local newspaper in 1980; Tim Carson charged £1 per visitor to a circle in 1990, and 7,000 visited the Eastfield Pictogram at Alton Barnes, near Milk Hill; Steve Woolgar; Sir Francis Graham-Smith of the Royal Society, who dismissed those people interested in crop circles as mixed company who talked a lot of rubbish and it was a profit-less business to get involved with people who were completely hooked on the unknown; Serena Roney-Dougal; a youthful-looking Matt Ridley of The Economist said that since episodes with nuclear power in the 1970s, people had questioned evidence that scientists had told them; physicist Terence Meaden, who founded TORRO; Yoshi-Hiko Ohtsuki of Waseda University, who researched ball lightning. Narrated by Gavin Weightman, directed by Jill Freeman, and produced by her husband Michael Wills, made by Juniper Productions 3 November Human Waste, new ways of treating excrement such as dry compost toilets, oxidation pools and greenhouses. Directed by Kate Woods (Australian), made by John Blake Associates
== Uses and examples == The use of peptides as drugs has some disadvantages because of their bioavailability and biostability. Rapid degradation, poor oral availability, difficult transportation through cell membranes, nonselective receptor binding, and challenging multistep preparation are the major limitations of peptides as active pharmaceutical ingredients. Therefore, small protein-like chains called peptidomimetics could be designed and used to mimic native analogs and conceivably exhibit better pharmacological properties. Many peptidomimetics are utilized as FDA-approved drugs, such as Romidepsin (Istodax), Atazanavir (Reyataz), Saquinavir (Invirase), Octreotide (Sandostatin), Lanreotide (Somatuline), Plecanatide (Trulance), Ximelagatran (Exanta), Etelcalcetide (Parsabiv), and Bortezomib (Velcade). Peptidomimetic approaches have been utilized to design small molecules that selectively target cancer cells, an approach known as targeted chemotherapy, by inducing programmed cell death by a process called apoptosis. The following two examples mimic proteins involved in key Protein–protein interactions that reactivate the apoptotic pathway in cancer but do so by distinct mechanisms. In 2004, Walensky and co-workers reported a stabilized alpha helical peptide that mimics pro-apoptotic BH3-only proteins, such as BID and BAD. This molecule was designed to stabilize the native helical structure by forming a macrocycle between side chains that are not involved in binding.
Sources: en.wikipedia.org
It is a synthetic peptide of 39 amino acids bearing a lipid side chain. Its size and architecture place it outside the small-molecule class, and laboratories generally handle it with the precautions used for biologic-like molecules.
The fatty diacid side chain promotes strong binding to serum albumin, which slows clearance and yields a half-life of roughly five days. That profile supports once-weekly administration in clinical use.
In vitro assays detect activity at both the GIP and GLP-1 receptors, but the activity ratio depends on the assay system and the signalling pathway measured. The relative contribution of each receptor to clinical effects is still being characterised.
It is normally kept frozen, desiccated, and away from light, with brief warming to room temperature before opening to limit condensation. Repeated freeze-thaw cycles are avoided because they stress the peptide. Once in solution, the material is held cold and used promptly.